Michelson Diagnostics (MDL) has raised more than ￡350,000 from a consortium of investors from the London Business Angels (LBA) network. The money will be used to support multi-centre clinical trials of its new hand-held multi-beam Optical Coherence Tomography imaging probe, which the company plans to launch in May or June this year. MDL received early-stage funding of ￡600,000 in October 2007 and a further ￡600,000 in July 2008, in rounds led by London Seed Capital with Catapult Venture Managers and LBA.
展开▼
